Latest News

Teva Reports Fourth Quarter and Full Year 2020 Financial Results

Teva Reports Fourth Quarter and Full Year 2020 Financial Results

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal...

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Gui...

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Rele...

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release S

Teva Reports Third Quarter 2020 Financial Results

Teva Reports Third Quarter 2020 Financial Results

Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremane...

Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab

Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate inj...

Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate injectio

China Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskine...

China Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskinesia i

Teva Reports First Quarter 2020 Financial Results

Teva Reports First Quarter 2020 Financial Results

Teva and Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumat...

Teva and Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid A

New Data For Teva AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets Inclu...

New Data For Teva AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets Included i

Teva Announces U.S. Launch of Autoinjector for AJOVY® (fremanezumab-vfrm) Injection

Teva Announces U.S. Launch of Autoinjector for AJOVY® (fremanezumab-vfrm) Injection